Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2

26 Dec 2023

Abstract excerpt

Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene cause autosomal dominant Parkinson’s disease (PD), with the most common causative mutation being the LRRK2 p.G2019S within the kinase domain. LRRK2 protein is highly expressed in the human brain and also in the periphery, and high expression of dominant PD genes in immune cells suggests involvement of microglia and macrophages in inflammation related to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Neurological diseases and metabolism
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38201257
DOI: 10.3390/cells13010053

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2PMID 38201257Read ↗

Differential LRRK2 signalling and gene expression in WT-LRRK2 and G2019S-LRRK2 mouse microglia treated with zymosan and MLi2Semantic proximity Read ↗

Nuclear ASC speck formation in microglia is associated with inflammasome priming and is exacerbated in LRRK2-G2019S Parkinson’s diseaseSemantic proximity Read ↗

<i>LRRK2</i> G2019S variant is associated with transcriptional changes in Parkinson’s disease human myeloid cells under proinflammatory environmentSemantic proximity Read ↗

LRRK2 G2019S variant is associated with transcriptional changes in Parkinson’s disease human myeloid cells under proinflammatory environmentSemantic proximity Read ↗

LRRK2 Kinase Mediates Increased GCase Activity in Microglia in Response to Proinflammatory StimuliSemantic proximity Read ↗

Nuclear ASC speck formation in microglia is associated with inflammasome priming and is exacerbated in LRRK2-G2019S Parkinson's disease.Semantic proximity Read ↗

Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures.Semantic proximity Read ↗

LRRK2 Is Involved in the IFN-γ Response and Host Response to PathogensSemantic proximity Read ↗

Leucine Rich Repeat Kinase 2 and Innate ImmunitySemantic proximity Read ↗

LRRK2 as a target for modulating immune system responses.Semantic proximity Read ↗

Vps35 p. D620N causes Lrrk2 kinase hyperactivity, chronic microglial activation and inflammationSemantic proximity Read ↗

LRRK2 G2019S and Parkinson's disease: insight from Neuroinflammation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.